Evotec SE, a global drug discovery and development partner for the biotechnology and pharmaceutical industry, has been making innovative strides in developing pharmaceuticals in a multitude of therapeutic areas, including but not limited to diabetes, CNS diseases, pain and inflammation, and oncology. With a wide array of collaboration agreements with industry leaders such as Pfizer Inc., Lilly, and Takeda Pharmaceuticals, Evotec SE remains at the forefront of drug innovation. Originating as Evotec AG in 1993, the company later changed its name to Evotec SE in April 2019 and is headquartered in Hamburg, Germany.
Evolution's ticker is EVO
The company's shares trade on the ASX stock exchange
They are based in Auckland, New Zealand
There are 1001-5000 employees working at Evolution
It is evolution.com/who-we-are
Evolution is in the Education & Training Services industry
The following five companies are Evolution's industry peers:
- Kip McGrath Education Centres